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CHAPTER 1 
 
Introduction 
 
1.1 Organ Analogues 
Sustained interest for alternatives to human testing for the validation of pharmaceuticals 
and for other directions of study have led to the development of many potential substitute 
models, both as a means to avoid the ethical concerns of testing potentially dangerous 
compounds on humans and to provide an affordable platform for determining the 
pharmacokinetic and pharmacodynamics properties of compounds of interest.  Evaluation of 
therapeutics has traditionally relied on preclinical testing using in vitro human cell cultures and 
in vivo studies in animal models to screen drug candidates for efficacy and safety prior to the 
beginning of clinical trials1.  These approaches provide a viable screening method to identify 
potential activity and obvious toxicity without risk to human subjects but also suffer from 
fundamental limitations.  The metabolism and biological structures of animal models obviously 
differ from corresponding human biology1 and consequently both the efficacy and potential 
toxicity of a given compound can vary widely between species.  Cell cultures can provide an 
environment with greater fidelity to human in vivo conditions than animal models but historically 
have provided only an incomplete picture of a drug’s metabolic pathway as they fail both to 
model organ to organ interactions and to provide compelling whole-organ environments2. 
These deficiencies have led to the development of new approaches in cell culturing to 
provide more complete testing models.  While bioreactors have long provided a means to 
generate biological compounds of interest3, there is an emerging use of purpose-designed 
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bioreactors intended to model whole organs for the study of cellular processes and metabolism4.  
Bioreactors utilized in this application tend to be small, with functional volumes of milliliters 
and total media reservoirs of less than 100 mL, and possess specialized structures for adherent 
mammalian cell culturing such as hollow-fiber5 or dynamic compression6 elements, in contrast to 
the multi-liter volumes and free-floating bacterial, yeast, or algal cultures of industrial 
bioreactors.  These bioreactors can accurately model both the anatomy of organ environments, 
using their structure to allow appropriate cell-to-cell interactions between the various cell lines 
that compose a given organ, and the environmental conditions of the organ, providing substitutes 
for mechanical stresses responsible for cell differentiation and orientation in real organs4.  A 
variety of approaches are used to achieve more in vivo-like conditions, ranging from substrates 
such as hydrogels7 and porous films8 that direct cell growth and orientation, fluidics that 
replicate shear stress9, and segregation structures that allow multiple cell lines to interact10.  
Changes in the environment of the cell dramatically alter the metabolism and secretome of the 
culture. 
On their own, biomimetic bioreactors provide compelling advantages over simple 
cultures in providing a platform both for the testing of compounds and for the elucidation of 
cellular mechanisms in animal tissues, but do not replicate the complex organ-to-organ 
interaction that are an advantage of animal models over cell cultures2.  Some effects of these 
interactions can be effectively mimicked, such as the addition of expected hormones and proteins 
to induce appropriate behavior and development or signaling molecules to produce desired 
cellular response11.  Other properties such as the effect of metabolic break-down products from 
an analyte from one organ on another organ, as seen in the conversion of methanol to 
formaldehyde and formic acid in the liver causing toxicity in optic nerves12 or the conversion by 
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the liver of codeine to morphine which acts on the neurons of the central nervous system13, are 
less easily anticipated and therefore difficult to test for in cell culture studies.  While this 
deficiency can be mitigated to some extent through processes such as the use of conditioned 
media14,15, a truly compelling replacement for animal models would need to reproduce the real-
time interactions between multiple organ systems. 
Increasingly compelling organ models have drawn interest towards models which 
integrate multiple artificial organs to create test platforms which more fully recreate the in vivo 
condition4.  Fluidic systems may recreate organ-to-organ interaction between multiple cell 
cultures by the distribution of running media from culture to culture in rates and pathways 
consistent with human physiology16.  Such a system would recreate the molecular conditions that 
help cells maintain differentiation and function and allow for the multi-organ metabolism that is 
responsible for both the efficacy and the side effects and toxicity of pharmaceutical compounds.  
With appropriate instrumentation, the system would provide a means to monitor the behavior of 
these cultures and thereby identify the effects and mechanism of action for compounds of interest 
in an environment considerably closer to a human subject than other current models.  Research 
efforts towards the construction of such systems utilize both bioreactors at conventional 
biochemical scales of mL volumes, for ease of study and size of yield, and organ-on-a-chip 
devices16 at μL volumes, with microfabrication and microfluidic technologies allowing for rapid 
prototyping17 and precise environmental control18. 
 
1.2 Blood Brain Barrier 
The properties of the blood-brain barrier (BBB), the cells at the interface of capillaries 
and the brain responsible for transport between these regions, make it a subject of particular 
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interest in pharmaceutical research.  Unless they are to be delivered intracranially, potential 
therapeutics targeting the brain must be able to cross the BBB to have effect.   As many 
significant medical conditions, such as majority of psychiatric disorders, Alzheimer’s disease, 
epilepsy, and others, originate in the brain, and because diseases of the brain very often result in 
substantial loss of quality of life the behavior of the BBB is a vital aspect to disease treatment19.  
While conventional chemical principles can guide the process of drug design through appeals to 
properties such as hydrophobicity and molecular analogy, the ability to test whether a novel 
compound will be able to cross the human BBB either through in silico or in vitro means provide 
substantial advantages in the early stages of drug development and testing20.      
The selective abilities of the BBB serve both to protect the brain from potential toxicity 
and to allow it to maintain a controlled environment where changes to local chemical 
concentrations are caused exclusively by cellular signaling rather than as a consequence of 
metabolism21.  This selectivity arise from the interaction of multiple cell types which work in 
conjunction22 to transport select molecules into or out of the brain through active and passive 
transport while excluding other materials by means of impermeable cell junctions and low rates 
of endocytosis15. The selective barrier is composed of specialized endothelial cells, very similar 
to the endothelial cells that form the lining of all blood and lymphatic vessels but differing in that 
endothelial cells of the BBB produce a network of interlocking proteins which resemble those of 
epithelial cells and create an impermeable barrier to diffusion15.  These networks consist of a 
combination of adherens junctions, found in most endothelial cells and formed by the anchoring 
of proteins included cadherens and catenins to the actin filaments of the cytoskeletons of 
adjacent cells to provide stability, and tight junctions, protein complexes consisting primarily of 
 5 
claudins and occludins which are embedded in the cell membranes of adjacent cells and which 
form a strongly hydrophobic barrier to prevent fluid diffusion15. 
    Beyond the endothelial cells are pericytes and astrocytes.  Pericytes are contractile 
cells with similarities to smooth muscle cells that provide additional structural support to the 
endothelium and allow the rate of blood flow through capillaries to be controlled through dilation 
and contraction of the capillary21.  Pericytes line the endothelial cells of the BBB as well as the 
rest of the vascular system21, though their importance to the function of the BBB is demonstrated 
by the barrier’s failure in pathological conditions caused by their absence or impaired function23.  
Astrocytes are process-bearing cells that act as an intermediate between the endothelial cells of 
the BBB and the neurons of the brain, providing chemical support and signal transfer to both22.  
Both pericytes and astrocytes have a roll in the establishment of the BBB, with the former 
providing additional physical junctions to supplement those of the endothelium21 while the later 
provides a means for the regulation of the BBB in response to changing conditions within the 
brain22.  Both maintain chemical contact with the endothelium and contribute biological factors 
primarily responsible for the generation and regulation of the junctions in between these cells22, 
though evidence suggests that astrocytes are responsible for the majority of this process15.   
Conventional approaches to cell culturing have largely failed to reproduce the robust 
junctions of the BBB during in vitro experiments14,24.  The permeability of the BBB is typically 
evaluated in by the measurement of electrical resistance across the barrier, a value given the label 
transepithelial electrical resistance (TEER) which is observed to range from 1000-2000 Ω-cm2 in 
a healthy BBB14.    In both in vivo endothelium outside the BBB and in in vitro monolayer 
cultures of endothelial cells originating from the BBB, TEER measurements of 5-10 Ω-cm2 are 
consistently observed14.  This low resistance indicates that substantial diffusion is possible 
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through the extracellular space within these samples.  Attempts to recreate the conditions of the 
BBB in culture have focused on cellular interactions, particularly by the addition of astrocytes, 
and mechanical stress, as there is substantial precedent that endothelial cells, like many other 
cells9, orient under the influence of shear stress25.  It is noted that most experiments which have 
achieved a substantial degree of success in emulating the BBB have managed to do so without 
the inclusion of pericytes, despite the demonstrated importance of these cells in in vivo 
conditions.  This is likely because the major chemical role of pericytes is protection of the 
endothelium from the immune system activity of microglia23, which are absent in these 
experiments, while the structural support provided by pericytes is to some degree supplied by the 
substrates used in these experiments. 
Past experiments have shown that culturing endothelial under conditions of fluid flow can 
raise TEER to values of 10-50 Ω-cm2, while the addition of media that has been conditioned by 
growth of astrocytes can induce endothelial cells to form junctions, increasing TEER values to 
the range of 50-200 Ω-cm2 14. Models co-culturing endothelial cells and astrocytes in 
environments that recreate fluidic stress on the endothelial cells have produced cultures with 
TEER in the range of 500-1000 Ω-cm2, indicative of substantial recreation of the BBB in in vitro 
conditions14.   It is noted that immunocytochemistry techniques have also shown an increase in 
the expression and organization of tight junction proteins as endothelial cells are subjected to 
conditions that more closely resemble the BBB14. 
 
1.3 PC-12 and HTB-10 (SK-N-MC) Cell Lines 
 A variety of immortalized cell lines are available as model substitutes for any particular 
type of primary cell.  In selecting a linage for a particular experiment, consideration should be 
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given to what particular properties are needed from the cells for the purpose of the model and 
whether the conditions of the model are conducive to the survival of the cell line.  Some lineages 
better reproduce the secretion profile of primary cells, while others are more morphologically 
similar or respond to stimuli more accurately.  Lines also have different requirements for use in 
experimentation.  Some lines require a stable substrate to which they may adhere and may or 
may not require adhesives such as a collagen film in order to thrive.  Cell lines may require 
particular nutrients or signaling factors either to survive or to maintain differentiation.  
Variations between organisms require consideration as to whether animal-derived cell-lines may 
substitute for human in a particular experiment or whether an immortalized cell line can even 
serve as a replacement for primary cells in a given model. 
 PC-12 cells and the derivative PC-12 adh line are an immortal cell line derived from a rat 
adrenal pheochromocytoma26.  PC-12 cells are non-adherent but PC-12 adh cells, which were 
developed by selection across multiple PC-12 cells, are weakly adherent.  Both lines can adhere 
to collagen-treated surfaces while the adh line can also adhere to Corning CellBIND® surfaces.  
The line can be maintained in RPMI-1640 medium supplemented with both horse serum and 
fetal bovine serum.  PC-12 cells exhibit many neuron-like properties26.  The line responds 
reversibly to nerve growth factor by developing processes and becoming susceptible to electrical 
excitability27,28.  PC-12 cells synthesize acetylcholine and the catecholamines dopamine and 
norepinephrine and will secrete these compounds in response to chemical or electrical 
stimulation in a manner consistent with neurotransmission28,29.  These properties make PC-12 
cells useful as a general surrogate for sympathetic neuronal cells, though it is noted that they are 
deficient in certain cell receptors found in neurons and in the production of the neurotransmitter 
epinephrine26.  The PC-12 cell line has been characterized by Multianalyte Microphysiometer 
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(MAMP) analysis30 and as a consequence its baseline metabolic activity and its response to 
certain stimulants are documented, providing a point of comparison for metabolic studies. 
 HTB-10 cells (also referred to as SK-N-MC cells) are an immortalized cell line derived 
from a metastasized human neuroblastoma31.  The lineage is robust, with a population doubling-
time of 32 hours, high achievable densities, and marked stability through culture passaging31.  
The cells can be maintained in Eagle’s minimum essential medium supplemented with fetal 
bovine serum.  Being of neurogenic origin HTB-10 cells possess neuronal properties, particularly 
the synthesis and storage of catecholamines31.  The cells are naturally adherent as a consequence 
of fibroblast-like character31 and do not require a collagen-coated surface to adhere or thrive in 
culture.  A related line, HTB-11 (SK-N-SH), is derived from a metastatic site of the same 
original tumor and displays similar morphology and behavior to the HTB-1031.  The HTB-11 line 
has been characterized by MAMP analysis32 and as a consequence its baseline metabolic activity 
and its response to certain stimulants are documented and provide a standard of comparison for 
HTB-10 behavior.  
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CHAPTER II 
 
Development and Validation of Multianalyte Screen-Printed Electrode  
 
2.1 Introduction 
The means to monitor the behavior and condition of an in vitro biological system is 
essential to both determine the results of experimentation on the system and to validate the 
model system in comparison to known behavior of the in vivo system being modelled.   The 
analytical demands for a biological model are steep, requiring means to monitor both the 
immediate health of the model to determine the stresses placed on it during experimentation 
while also identifying and quantitating the diverse biomolecules including proteins, hormones, 
and cytokines which provide insight to the interactions of the system by their disturbance.  
Methods must be able to meet this demand through the analysis of the complex mixture of cell 
media, preferable in real-time. 
Electrochemistry techniques have consistently demonstrated utility in the analysis of the 
small molecules in complex biological environments with a high degree of specificity and 
selectivity.  Electrodes treated with enzymatic coatings can be made selective to particular 
molecules of interest33,34 while other applications can provide sensitivity to environmental 
conditions of interest such as solution pH35, conductivity36, and temperature36.  Electrode sensors 
are capable of continuous rapid sampling and when appropriately designed are minimally 
disruptive to the environment being sampled37.   
Energy metabolism provides substantial insight into the health of a biological system, 
with shifts from aerobic to anaerobic processes indicative of stress on the system and net changes 
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in respiration indicative of cell reproduction or death38.  Glucose and oxygen are consumed as 
result of energy metabolism and changes in their concentration provide a means to measure the 
rate of cellular respiration38,39.  Likewise, the production of lactic acid provides an indication of 
anaerobic respiration39, while acidification is a result of all respiration as a consequence of 
dissolved CO2 produced38.  The properties of electrochemical techniques are well suited to 
measure changes in these analytes in order to observe the health of biological models.    
Interest in monitoring cell behavior in this way led to the development of the   
Multianalyte Microphysiometer (MAMP) by the laboratory of Dr. David Cliffel.  Acting as an 
extension of the previous CytosensorTM Microphysiometer, the MAMP utilized a variety of 
specialized electrodes to monitor the respiration of cell cultures as they were subjected various 
experimental protocols.  The MAMP’s utility has been demonstrated in a number of studies 
including evaluation of neuronal stress responses in simulated stroke conditions40,41, quantitation 
of cancer cell metabolism42, evaluation of the effects common fluorescent dyes used in cellular 
staining on metabolism43, and the mechanisms of action of cholera toxin30.  These results have 
shown that the MAMP can not only quantify the effects of compounds of interest but also 
identify specific mechanisms of action and intracellular processes by measuring despite 
measuring only a few key analytes.  This is possible through the administration of compounds 
which activate and inhibit specific cellular processes alongside the compound of interest, a 
process somewhat analogous to the use of gene knockout to study metabolic pathways. 
The MAMP quantifies analytes by a variety of means.  Some electrode treatments rely on 
enzyme films.  Within these films, analytes such as glucose33 or lactate44 are degraded by 
appropriate oxidase enzymes in a process that produces hydrogen peroxide.  By holding the 
electrode at a sufficiently high potential to oxidize this peroxide, the rate of oxidation at the 
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platinum surface of the electrode can be measured amperometrically to quantify the analyte.  
Oxygen is detected through the use of an unmodified platinum electrode held at a sufficiently 
negative potential to reduce oxygen45. Evaluation of solution pH, the original function of the 
Cytosensor, is performed by open-circuit potential measurement using light-addressable 
potentiometric sensor. 
Applications of the MAMP’s detection principles to system such as bioreactor organ 
models or multi-organ systems has led to the development of a more flexible detector in the form 
of a Multianalyte Screen-Printed Electrode (SPE), which sets aside the dedicated pumping 
systems and cell chambers of the MAMP in order to achieve concise design that is easily 
integrated into both new and existing cell culturing systems.  The SPE constitutes a series of five 
platinum electrodes deposited on a ceramic base and insulted by an additional layer of clear 
ceramic which covers the whole of the electrodes except for an exposed working area and 
contact points for connection to a potentiostat.  With one silver-plated electrode acting as a 
Ag/AgCl reference, each of the four remaining electrode can be independently modified by the 
application of films to target desired analytes. Sampling is conducting on fluid pumped over the 
electrode surface from either an upstream population of cells or from a culture inside the SPE 
housing. 
Evaluation of the SPE with various electrode treatments and conditions have allowed 
validation and optimization of the device and associated procedures to prepare for its use as a 
next-generation MAMP in a variety of biochemical applications.  The results of these 
experiments contributed to others which have concluded in the success reproduction of former 
MAMP experiments and the preparation of the SPE for instrumentation of model biological 
systems46.   
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2.2 Experimental Procedures 
 2.2.1 Reagents and Instrumentation 
  50 mM pH 7 phosphate buffer solution, silver nitrate, sulfuric acid, 
potassium ferricyanide, and sodium lactate were obtained from Fisher 
Scientific.  30% hydrogen peroxide, oxalic acid, bovine serum albumin, 
and gluteradehyde were obtained from Sigma-Aldrich.  Iridium 
tetrachloride, iron trichloride, platinum used in counter electrodes, and 
Nafion were obtained from Alfa Aesar.  20% glucose solution was 
obtained from Life Technologies.  Stabilized glucose oxidase and lactate 
oxidase were obtained from Applied Enzyme Company.  Electrochemical treatments were 
applied using a Ag/AgCl electrode, a 660A Electrochemical Workstation, and a Picoamp Booster 
Faraday Cage from CH Instruments.  Electrochemical measurements were performed on a 
multichamber multipotentiostat capable of two amperometric and one potentiometric 
measurement against a reference electrode, controlled by LabVIEWTM software and described in 
existing literature47.  Fluidic pumping was performed with Harvard Apparatus PicoPumps. 
Screen-printed electrodes and accompanying housing were designed by Dr. Jennifer 
McKenzie and fabricated by Pine Research Instrumentation. 
 2.2.2 Electrode Film Preparations 
Prior to treatment, all electrodes were cleaned by immersion in 1 M H2SO4 accompanied 
by cyclic voltammetry.  An applied potential swept from 0.15V to 0.8V and back repeatedly at a 
scan rate of 0.5 V/s.  Cleaning continued until no substantial changes were observed between 
subsequent cyclic voltammagrams.  Care was taken to ensure that the final step was always from 
less to more positive voltages to prevent redeposition of hydroxides and oxides.       
 
Figure 1 – A single unmodified SPE. 
 13
Silver/silver chloride quasi-reference electrodes were prepared by constant-current 
electrodeposition of silver and subsequent conditioning according to a previously developed 
procedure48.  A solution of 0.3 M AgNO3  in 1 M ammonia was prepared.  An electrode placed 
in this solution was preconditioned for plating by the application of +0.95V for 30 seconds in 3M 
KCL solution.  The electrode was then subjected to an applied current of 6.5 mA/cm2 for 450 
seconds.  The resulting silver film was submerged in 50 mM FeCl3 for 60 seconds to create a 
surface layer of AgCl.  All solutions were agitated with a stir bar during treatment. 
pH-sensitive IrO2 electrodes were prepared by constant-potential electrodeposition in an 
iridium oxalate solution according to the method described by Ges49.  The iridium oxalate 
solution was prepared by dissolution of 37.5 mg of IrCl4 in 25 mL DI water aided by stir-bar 
mixing.  After 15 minutes, 30% H2O2 was added and the solution was allowed to continue to 
mix.  10 minutes thereafter 125 mg oxalic acid was added.  After an additional 10 minutes, the 
solution was brought to pH 10.5 by the addition of potassium carbonate.  The resulting solution 
was allowed to develop at room temperature in darkness for a minimum of five days and was 
then stored at 4° C.   Electrodes to be treated were immersed in developed iridium oxalate 
solution and preconditioned by the application of -0.6 V for 30s.  Iridium was plated by the 
application of +0.6 V for seven minutes, resulting in a visible purple film on the plated electrode.  
The iridium oxalate solution was agitated with a stir bar during treatment. 
Glucose, lactate, and oxygen sensors were prepared by application of enzyme and 
polymer films.  All enzyme films were prepared in a base mixture composed produced by the 
mixture of 800 μL of phosphate buffer and 50 mg of bovine serum albumin. Glucose-sensitive 
films were prepared by the dissolution by vortexing of 1.5 mg of stabilized glucose oxidase in 
300 μL of buffer-serum mixture.  3 μL of glutaraldehyde were added to the solution which was 
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again vortexed for 5 seconds.  Lactate-sensitive films were prepared by the same process, using 
2.5 mg lactate oxidase, 100 uL of buffer-serum mixture, and 0.8 μL glutaraldehyde.  Enzyme 
films were hand-cast using 200 μL pipette tips.  Enzyme-film electrodes and oxygen-sensing 
electrodes were coated with a hand-cast film of Nafion polymer to improve electrode selectivity.  
All films were allowed to dry for 30 minutes prior to further treatment or storage. 
After any treatment, SPEs were stored in buffer solution at 4° C.  Enzyme electrodes 
were typically allowed to age 1-2 days prior to improve the stability of their response.  
2.2.3 Electrochemical Measurements 
Electrochemical quantitation of analytes in solution was performed using the 
multichamber multipotentiostat to monitor the response of modified SPEs.  Glucose and lactate 
were measured amperometrically by the application of +0.6 V to the corresponding working 
electrode relative to the quasi-reference electrode.  Oxygen was measured amperometrically by 
the application of -0.45V relative to the quasi-reference electrode to the corresponding working 
electrode.  Changes in pH were quantified by changes in the open-circuit potential between the 
corresponding working electrode and the quasi-reference electrode. 
Calibration solutions were prepared by dilution from previously prepared glucose and 
lactate solution.  Oxygen and pH were measured but not calibrated throughout the experimental 
process.  
2.2.4 Electrode Reclamation 
A protocol for the attempted reclamation of treated electrodes which had lost 
effectiveness or for which a new treatment was desired was developed.  All tested protocols 
consisted of the immersion of modified electrodes into solutions of buffer or nitric acid and the 
application of a constant voltage vs a Ag/AgCl reference electrode. 
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2.3 Results and Discussion 
2.3.1 Calibration of Optimized Sensors 
Initial experiments focused on validating the abilities of the SPE device while 
determining areas for improvement.  A series of calibrations identified frequent points of failure 
which were addressed by either structural modifications or procedural changes in the SPE and its 
use.  These modifications improved the consistency and ease of use of the SPE and provided 
benchmarks as to the device’s dynamic range for various analytes.   
 
 Figure 2 – Comparison before and after implementation of a membrane to reduce the impact of bubbles caught in SPE microfluidics, demonstrating noise reduction.  Modifications to the SPE housing aimed primarily at improving repeatability and sensitivity.  
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Particularly attention was 
directed towards the behavior of 
the glucose and oxygen enzyme 
electrodes during the iterative 
process and it was observed that 
quantitation of these analytes 
noticeably influences the detection of oxygen.  The enzyme electrodes demonstrated linear 
behavior throughout the range of interest without need for correction of Michaelis-Menten 
kinetics.  After the completion of these improves, the electrodes demonstrated a response of 
(220±20) ௡஺௠ெ for glucose and (620±40) ௡஺௠ெ for lactate.  Modifications developed during the 
optimization process contributed to further improvements by other 
researchers and to the design of the standardized SPE housing and the 
standard operating protocols for its use. 
2.3.2 Electrode Recovery  
Treated electrodes were subjected to various environmental 
conditions and electrochemical treatments in an attempt to remove applied 
films without damage to the underlying platinum electrodes.  Initial efforts 
utilized mild conditions, specifically 50 mM phosphate buffer solution, and 
electrical potentials of 1.0, 1.05, and 1.15V, within the electrochemical 
window of platinum but failed to noticeably degrade either metal or enzyme 
films.  A series of progressively higher potentials (1.2, 1.5, 2.0, 2.5, 5, and 
10V) were applied and demonstrated limited success, causing slow stripping 
of metal films and damaging but not removing enzyme films.  Sustained 
a   
b   
c   
d   
e   Figure 4 – 100x magnification of (a) untreated electrode  (b) enzyme film  (c)Ag/AgCl film (d)IrOx film (e)recovered electrode 
  Figure 3 – Example calibration results following iterative improvement.  
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application of high potentials (10V) in a solution of 0.5M sulfuric acid resulted in the rapid (<30 
seconds) degradation of enzyme films and eventual (~40 minutes in the case of Ag/AgCl) 
removal of metal films.  Stripped electrode performance was compared to the behavior of fresh, 
unmodified electrodes by cyclic voltammetry in a solution of 5mM ferricyanide.  Compared to 
the control electrodes, recovered electrodes produced nearly-identically shaped voltammograms 
with overlapping peaks but exhibited larger current magnitudes.  The enhanced electrode 
response was attributed to the combination of more complete removal of any passivating layers 
on the electrode and the possible increase of electrode surface area due to surface area.  While 
the conditions of the experiment were sufficient to oxidize the platinum of the electrode, no such 
damage was observed.  The stability of the electrodes may stem from the considerable kinetic 
favorability of water electrolysis over platinum oxidation.     
 
Figure 5 – Comparison of cyclic voltammograms from a recovered electrode previously treated by application of an enzyme film (red) to and unmodified control (blue).    CVs were conducted in 5mM ferricyanide over a range of 0.5 to -0.1V, at a 0.1V/s scan rate.  Additional CVs showing comparisons for enzyme, silver/silver chloride, and iridium oxide films both prior and following recovery are included in the appendix of this document.  2.4 Conclusions 
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Protocols and device modifications developed during testing and in response to problems 
observed during testing contributed significantly to the preparation of the SPE platform for wider 
use as an analytical platform, contributing to its reliability and ease of use.  A version of the SPE 
utilizing these and other improvements is described in literature46.  A refined version of the 
electrode recovery procedure is included in the standard operating procedures available to 
Vanderbilt Institute for Integrative Biosystems Research (VIIBRE) members and their 
collaborators for integration of the SPE platform in their experiments.   The development of a 
reliable standard protocol for the SPE device is a necessary step in the electrochemical 
instrumentation of model biological systems, efforts towards which are described in the 
following chapter.  
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CHAPTER III 
 
Towards Real-Time Electrochemical Monitoring of Metabolism 
in Hollow Fiber Bioreactor Cellular Cultures  
 
3.1 Introduction 
A substantial motivation in the development of model biological systems is to provide 
reliable testing platforms to study the effects of potential therapeutic compounds without risk to 
living patients.  Models of the blood-brain barrier (BBB) are a matter of particular interest in this 
field as, depending on its application, a candidate compound’s ability or inability to cross the 
barrier can be an overwhelming obstacle to its clinical application.  State of the art BBB models 
recapitulate the in vivo environment in considerable detail, recreating the cellular interactions 
and the physical environment of the BBB24.  One such barrier model, the FloCel Hollow Fiber 
Bioreactor (HFBx), has served as a test candidate for integration of the Multianalyte Screen-
Printed Electrode developed by the Cliffel lab as a means to monitor the metabolic activity of 
cell cultures in the bioreactor. 
The HFBx’s design consists of three chambers, with the outer chambers on each side 
connected to one another by a series of porous hollow fibers that pass through the central 
chamber. Two ports connect to the central chamber to allow for the filling of the chamber and 
while another port connects to each of the end chambers to allow for cell loading and fluid flow 
through the device.  Four gold electrodes allow measurement of the conductivity between the 
inner and outer chambers.  Fluid is pumped through the device by a pulsatile pump which allows 
independent control of flow and pulse rates.  In BBB experiments, the insides of the hollow 
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fibers are seeded with endothelial cells while astrocytes are cultured in the central chamber.  
Other cell lines such as neuronal or immune cells may also be co-cultured in the central chamber 
as the needs of individual experiments dictate.  The pores of the fibers allow chemical contact 
between the cell populations.  By allowing interaction between the endothelial and astrocytic 
populations consistent with human anatomy22 and reproducing the shear strain pumped blood 
would exert through the pulsatile flow of media through the hollow fibers25, the HFBx can 
induce organization and behavior in the endothelial cells that is substantially closer to in vivo 
BBB endothelium than that of endothelial cells maintained in a traditional 2D culture.  
Integration of the SPE to the HFBx presents substantial challenges.  As many of the 
electrodes of the SPE chip utilize enzyme films to achieve their selectivity, processes which 
would sterilize the chip would also degrade the films.  The activity of the enzymes does not 
survive autoclaving or applications of sterilant solutions.  As recirculation of media is necessary 
in the HFBx in order to allow accumulation of biomolecules in the media, even downstream 
contamination endangers the bioreactor.  As the response of the SPE varies with flow rate, the 
pulsatile pump of the HFBx introduces substantial noise in analyte quantitation.  Diffusion 
between the outer and central chambers of the HFBx, while desirable during the maintenance 
and monitoring of a culture in recirculating media which will come to equilibrium, presents a 
complication to SPE calibration.  The effects of these and other challenges have been considered 
and possible solutions are proposed to many of them.  
 
3.2 Experimental Procedures 
2.2.1 Reagents and Instrumentation 
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F-12K medium, gentamicin-sulfate, and type I collagen were obtained from Life 
Technologies.  Dulbecco’s modified Eagle’s medium, PC-12 adh cells (CRL-1721.1), and SK-N-
MC cells (HTB-10) were obtained from the American Type Culture Collection.  Heat-inactivated 
horse serum and fetal bovine serum were obtained from Atlanta Biologicals.  FloCel hollow-
fiber bioreactors and accompanying TEER platform, pulsatile pump, and assorted fluidics 
materials were provided by FloCel Inc. along with permission to reproduce existing 
representations of their materials or their capabilities.   Fluidic adaptors and tubing were obtained 
from IDEX Health & Science, with the exception of three-way stopcocks which were obtained 
from SAI Infusion Technologies and 0.20 μm filters which were obtained from Fisher Scientific.  
Additional pumping needs were met by a MasterFlex peristaltic pump from Cole-Palmer and by 
a rotary planar peristaltic micropump provided by VIIBRE.  A VWR water-jacketed CO2 
incubator was used for the maintenance of cell cultures in the bioreactor. Supplies and devices 
for the SPE are identical to those described in the previous chapter. 
2.2.2 SPE Protocols 
Measurements with the SPE were conducted as described in the previous chapter with minor 
alterations.  Fluid flow to the SPE was regulated by the use of a peristaltic pump to allow a 
degree of isolation from the action of the pulsatile pump.  The interface between the SPE and the 
bioreactor is described in section 2.2.4. 
2.2.3 Cell Culturing 
Cell lines were maintained under the conditions and according the protocols specified by the 
ATCC for each cell line.  All cell handling was performed inside a Class II biosafety cabinet 
2.2.4 Bioreactor Loading and Maintenance 
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The FloCel HFBx and associated components were sterilized prior to assembly and cell 
loading.  The media reservoir bottle and its cap along with the bioreactor cartridge and its caps 
were sterilized by autoclaving at 121° C for 45 minutes, while the remaining fluidic components 
were sterilized by immersion in or pumping through of AquaMax® sterilant (1000 parts sterilant 
stock: 1 part bleach mixed immediately prior to application) for a minimum of 24 hours prior to 
assembly.  All solutions used in the cabinet which contacted the interior of the bioreactor system 
were filtered by use of a syringe filter or filter flask prior to use.  All sterile components were 
transferred into a biosafety cabinet still sealed.   The outer surfaces of tubing were disinfected by 
spraying with 70% isopropyl alcohol (IPA) during the transfer process.   
The fibers of the bioreactor were wetted by administration of 10 mL through one outer 
chamber port into an empty syringe at the other outer chamber port.  The fibers were allowed to 
wet for at least one minute after which that ethanol which could not removed by the action of a 
syringe was displaced by deionized water (DI) administered according to the same procedure.   
In cases where the fibers of the bioreactor were treated with collagen, a collagen film was 
applied by the passage of a filtered portion of 1mg/mL collagen solution administered from a 
syringe attached at outer chamber port to the opposite inner chamber port and back, and then 
repeated using the remaining outer and inner chamber ports.  The fibers were allowed to soak in 
the collagen solution for one hour.  This procedure results in the collagen treatment of both the 
interior and exterior surfaces of the hollow fibers. 
Cells were loaded into the bioreactor by gentle passage of 10 mL of cell suspension between 
an inner and opposite outer port pair and then repeated by the remaining port pair.  For loading 
of cells to the interior of the hollow fibers, cell suspension should be passed from outer to inner 
ports, while the loading of cells in the central chamber is accomplished by passage of cell 
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suspension from inner to outer ports.  Following application of cells to the inner surfaces of the 
fibers, a process not utilized in this work, the bioreactor should be allowed to rest in a sealed 
state for one hour within an incubator, being rotated 180° around the axis parallel to the fibers 
after thirty minutes to ensure complete surface coverage.   
Assembly of the bioreactor and fluidic systems followed cell loading.  Sterilant solution was 
displaced from the fluidics by manual pumping of deionized water followed by cell media.  Prior 
to the opening of any fluidic link the link was sprayed with 70% IPA.  A three-way stopcock and 
a 0.20 μM sterile filter were attached to the outer port which would be downstream relative to 
pulsatile pump flow. The bioreactor was connected by attachment of appropriate fluidic links to 
its remaining outer port and to the remaining port of the three-way stopcock, which should be 
configured to allow recirculating flow while sealing the filter.  The media reservoir was filled 
with 25 mL of the appropriate media and attached to the fluidics. The assembly was removed 
from the biosafety cabinet, attached to its TEER platform and pulsatile pump, and placed in an 
incubator.  Following cell loading, the bioreactor was maintained by the circulating action of the 
pulsatile pump and by media replacement when acidification or glucose depletion of the media 
became significant. 
2.2.5 Bioreactor Configuration and Sampling 
For sampling, appropriate instrumentation was connected to the 0.20 μM sterile filter 
following application of 70% IPA to both the filter and the fluidic being attached.  
Instrumentation consisted of a peristaltic pump, optional inclusion of an SPE chamber, and either 
a collection vessel or biological waste receptacle. No effort was made to sterilize the attached 
fluidics downstream of the filter to avoid potential contamination of collected samples or 
degradation of the enzyme films of the SPE.  Sampling of the running media in the bioreactor 
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was sampled by the complete opening of the three-way stopcock to allow media to be pulled 
through the filter by the action of the peristaltic pump.      
3.3 Results and Discussion 
3.3.1 Evaluation of Integrated SPE Sensitivity 
Three-point calibration experiments using the SPE in monitoring the HFBx revealed a 
substantial reduction in sensitivity compared to previous calibration experiments using the SPE 
platform.   The observed response for these experiments was (94±1)nA/mM+7±2nA for glucose 
and (275±86)nA/mM±11nA for lactate, under half that observed in previous calibrations.     
This loss of sensitivity was attributed to diffusion between the inner and outer chambers of the 
bioreactor, resulting in each calibrant solution mixing with the previous solution.  Measurements 
performed while glucose- and lactate-free media was circulated through the inner chamber 
showed less than 25% of the expected signal response compared to previous SPE calibrations.  
As the HFBx utilizes recirculating media to promote the accumulation of signaling molecules 
from cultured cells, it may be expected that inner and outer chamber conditions will reach 
equilibrium given sufficient time.  Under sampling conditions these diffusion effects are 
tolerable (and even desirable, in that they provide insight into the activity of cells cultured in the 
inner chamber even when sampling from the recirculating line) but during experiments where the 
 
Figure 6 – Three-Point Calibrations through the FloCel Inc. Bioreactor 
 25
culture is perturbed, such toxicology or drug candidate studies, are likely to suffer from poor 
time resolution and signal intensity relative to similar experiments in devices like the MAMP.  
An additional sensitivity study was initiated to examine signal response to prepared cell medium 
but was abandoned when it became evident that medium mixed with any substantial amount of 
serum had lactate concentrations sufficient to completely saturate current lactate oxidase enzyme 
electrodes.    
3.3.2 Evaluation of Integrated SPE Effects on System Sterility  
Cells were cultured in the HFBx and the system was subjected to simulated sample 
collection to determine whether the sterile filter and associated procedure were sufficient to 
preserve the sterility of the HFBx.  Initial results utilizing PC-12 cells were inconclusive; after 
operation for ten days with no apparent depletion of the running media, the HFBx was inspected 
it was found that setting of applied collagen had entirely obstructed the fibers of the bioreactor 
and caused the bioreactor media to crystalize.  No media could be extracted from the bioreactor 
chambers.  Upon inspection using a hemocytometry microscope, no evidence of contamination 
or of PC-12 cells was observed in the media reservoir with or without the addition of trypan blue.  
Inspection by microscopy of media taken from the sampling line revealed clusters of a fibrous 
red organism in the media.      
Sterility experiments were repeated with naturally adherent HTB-10 cells in order to 
avoid the use of collagen.  Media was sampled regularly and changed weekly by replacement of 
the reservoir bottle.  The sampling line showed consistent evidence of contamination as in the 
previous PC-12 experiment but inspection of the replaced media showed no sign of 
contamination either from the sampling line or from passage of HTB-10 cells through the pores 
of the HFBx.  After three weeks of operation, the media of the inner chamber was removed and 
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the remaining contents of the chamber extracted by treatment with trypsin.  The removed media 
contained HTB-10 cells confirmed as dead by universal staining by trypan blue.  The trypsin-
extracted sample contained primarily living HTB-10 cells.  No evidence of contamination by 
other organisms was observed in either sample.  No electrochemical analysis of collected 
samples was conducted as the lactate concentration in media containing more than 5% fetal 
bovine serum was known to exceed the detection limit of SPE enzyme film applications 
available at the time of testing.      
 
3.4 Conclusions 
Both fundamental challenges of integrating the SPE to new experimental platforms and 
specifically obstacles in doing so with the FloCel HFBx or similar devices have been identified.  
It was seen in some cases, such as preserving the sterility of the HFBx during sampling, that 
appropriate protocols can resolve obstacles without compromising the function of the HFBx or 
the SPE.  The implementation of printed enzyme film techniques which have since been 
developed for the SPE address the difficulties in lactate quantitation in media.  While the effects 
of diffusion between the inner and outer chambers introduce a complication in the time 
resolution of cellular response experiments, it is one that can be accounted for in the analysis of 
collected data and is unlikely to be observed in experiments that fully recapitulate the BBB and 
thereby prevent unmediated diffusion through the fibers.  These experiments provide a clear path 
to a more substantial demonstration of the viability of integrated SPE-bioreactor platforms.  
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APPENDIX 
  Figure A1 - Comparison of cyclic voltammograms from an electrode with an applied silver/silver chloride film(red) to and unmodified control (blue).  CVs were conducted in 5mM ferricyanide over a range of 0.5 to -0.1V, at a 0.1V/s scan rate.  
   Figure A2 - Comparison of cyclic voltammograms from an electrode with an applied enzyme film (red) to and unmodified control (blue).  CVs were conducted in 5mM ferricyanide over a range of 0.5 to -0.1V, at a 0.1V/s scan rate.  It is noted that the film substantially reduces the magnitude of current at any given potential.    
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  Figure A3 - Comparison of cyclic voltammograms from an electrode with an applied iridium oxide film (red) to and unmodified control (blue).  CVs were conducted in 5mM ferricyanide over a range of 0.5 to -0.1V, at a 0.1V/s scan rate.  
  Figure A4 – Comparison of cyclic voltammograms from a recovered electrode previously treated by application of a silver/silver chloride film (red) to and unmodified control (blue).    CVs were conducted in 5mM ferricyanide over a range of 0.5 to -0.1V, at a 0.1V/s scan rate.   
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  Figure A5 – Comparison of cyclic voltammograms from a recovered electrode previously treated by application of a enzyme  film (red) to and unmodified control (blue).    CVs were conducted in 5mM ferricyanide over a range of 0.5 to -0.1V, at a 0.1V/s scan rate.  This figure is present in the body of the text as Figure X  
  Figure A6 – Comparison of cyclic voltammograms from a recovered electrode previously treated by application of a iridium oxide chloride film (red) to and unmodified control (blue).    CVs were conducted in 5mM ferricyanide over a range of 0.5 to -0.1V, at a 0.1V/s scan rate.   
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